India, Nov. 11 -- image credit- shutterstock

Servier India,a subsidiary of the leading French pharmaceutical company Servier Group, has announced the launch of a patient-centric biomarker testing initiative in collaboration with leading genomic laboratories MedGenome and Strand Life Sciences.

As part of this initiative, a customised panel of biomarker tests forAcute MyeloidLeukaemia(AML), an aggressive blood cancer andCholangiocarcinoma (CCA), a rare bile duct cancer, is launched across India atsubsidised ratesmaking these advanced diagnostics moreaffordable and accessible.

The panel will be available to healthcare professionals acrossprivate and government sectors.Specifically,IDH1 and IDH2 mutation testing for AML and CCA, will be av...